Your browser doesn't support javascript.
loading
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
Mir, Romaana; Kelly, Sarah M; Xiao, Ying; Moore, Alisha; Clark, Catharine H; Clementel, Enrico; Corning, Coreen; Ebert, Martin; Hoskin, Peter; Hurkmans, Coen W; Ishikura, Satoshi; Kristensen, Ingrid; Kry, Stephen F; Lehmann, Joerg; Michalski, Jeff M; Monti, Angelo F; Nakamura, Mitsuhiro; Thompson, Kenton; Yang, Huiqi; Zubizarreta, Eduardo; Andratschke, Nicolaus; Miles, Elizabeth.
Affiliation
  • Mir R; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Mount Vernon Cancer Centre, United Kingdom. Electronic address: romaana.mir@nhs.net.
  • Kelly SM; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium; Quality and Excellence in Radiotherapy and Imaging for Children and Adolescents with Cancer across Europe in Clinical Trials (QUARTET) Project, SIOP Europe, Brussels, Belgium.
  • Xiao Y; Imaging and Radiation Oncology Core (IROC), University of Pennsylvania, Philadelphia, United States.
  • Moore A; Trans Tasman Radiation Oncology Group (TROG), Newcastle, Australia.
  • Clark CH; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Royal Surrey NHS Foundation Trust, United Kingdom; National Physical Laboratory (NPL), Teddington, United Kingdom.
  • Clementel E; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Corning C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Ebert M; Trans Tasman Radiation Oncology Group (TROG), Newcastle, Australia; Sir Charles Gairdner Hospital and University of Western Australia, Australia; School of Physics, Mathematics and Computing, University of Western Australia, Australia.
  • Hoskin P; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Mount Vernon Cancer Centre, United Kingdom.
  • Hurkmans CW; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  • Ishikura S; Japan Clinical Oncology Group (JCOG), Japan; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kristensen I; Radiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Sweden.
  • Kry SF; Imaging and Radiation Oncology Core (IROC), The University of Texas MD Anderson Cancer Center, United States.
  • Lehmann J; Trans Tasman Radiation Oncology Group (TROG), Newcastle, Australia; Department of Radiation Oncology, Calvary Mater Hospital and School of Mathematical and Physical Sciences, University of Newcastle, Australia.
  • Michalski JM; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, United States.
  • Monti AF; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium; Department of Medical Physics, ASST Niguarda Hospital, Milan, Italy.
  • Nakamura M; Japan Clinical Oncology Group (JCOG), Japan; Division of Medical Physics, Department of Information Technology and Medical Engineering, Human Health Sciences Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Thompson K; Trans Tasman Radiation Oncology Group (TROG), Newcastle, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Yang H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Zubizarreta E; Applied Radiation Biology and Radiotherapy Section, Division of Human Health, International Atomic Energy Agency (IAEA), Vienna, Austria.
  • Andratschke N; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium; Department of Radiation Oncology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Miles E; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Mount Vernon Cancer Centre, United Kingdom.
Radiother Oncol ; 150: 30-39, 2020 09.
Article in En | MEDLINE | ID: mdl-32504762
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality Assurance, Health Care / Radiotherapy Planning, Computer-Assisted / Organs at Risk Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Language: En Journal: Radiother Oncol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality Assurance, Health Care / Radiotherapy Planning, Computer-Assisted / Organs at Risk Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Language: En Journal: Radiother Oncol Year: 2020 Document type: Article Country of publication: